SCHEMBL798809

SCHEMBL798809

Nc1nc(N)c(N)c(N2CCN(F)CC2C(=O)c2cccc3ccccc23)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
USP2 O75604 1/20 0.37
KDM2B Q8NHM5 1/20 0.37
ALDH1A1 P00352 4/20 0.37
LMNA P02545 3/20 0.37
POLB P06746 2/20 0.36
MAPT P10636 1/20 0.35
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
DHFR P00374 1/20 0.33
NPC1 O15118 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694600 0.89 GAA (0.38) GAAUSP2KDM2BALDH1A1LMNA
SCHEMBL655440 0.82 HTR6 (0.36) GAAKDM2BALDH1A1LMNAPOLB
SCHEMBL798905 0.81 GAA (0.39) GAAUSP2KDM2BALDH1A1LMNA
SCHEMBL798958 0.78 DHFR (0.36) KDM2BKMT2ADHFRMEN1
SCHEMBL798970 0.76 DHFR (0.42) KDM2BALDH1A1LMNAKMT2ADHFR
SCHEMBL798577 0.71 TP53 (0.34) GAAALDH1A1LMNAMAPTKMT2A
SCHEMBL654041 0.64 HTR6 (0.36) GAAKDM2BALDH1A1LMNAPOLB
SCHEMBL3399717 0.62 GAA (0.56) GAAKDM2BALDH1A1LMNAPOLB
SCHEMBL28611110 0.60 GAA (0.54) GAAKDM2BALDH1A1LMNAPOLB
SCHEMBL11762859 0.59 GAA (0.60) GAAKDM2BALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed